Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Nanoparticle Based Combination Treatments for Targeting Multiple Hallmarks of Cancer.

VanDyke D, Kyriacopulos P, Yassini B, Wright A, Burkhart E, Jacek S, Pratt M, Peterson CR, Rai P.

Int J Nano Stud Technol. 2016;Suppl 4:1-18. Epub 2016 Jul 27.

2.

Aptamer-nanoparticle complexes as powerful diagnostic and therapeutic tools.

Jo H, Ban C.

Exp Mol Med. 2016 May 6;48:e230. doi: 10.1038/emm.2016.44. Review.

3.

Hydrolysable core crosslinked particle for receptor-mediated pH-sensitive anticancer drug delivery.

Liu X, Miller AL 2nd, Waletzki BE, Mamo TK, Yaszemski MJ, Lu L.

New J Chem. 2015 Nov 1;39(11):8840-8847. Epub 2015 Sep 3.

PMID:
27134519
5.

The Research and Applications of Quantum Dots as Nano-Carriers for Targeted Drug Delivery and Cancer Therapy.

Zhao MX, Zhu BJ.

Nanoscale Res Lett. 2016 Dec;11(1):207. doi: 10.1186/s11671-016-1394-9. Epub 2016 Apr 18. Review.

6.

Subcellular Behaviour Evaluation of Nanopharmaceuticals with Aggregation-Induced Emission Molecules.

Xue X, Xu J, Wang PC, Liang XJ.

J Mater Chem C Mater Opt Electron Devices. 2016 Apr 14;4(14):2719-2730. Epub 2016 Jan 27.

PMID:
27042309
7.

A RNA-DNA Hybrid Aptamer for Nanoparticle-Based Prostate Tumor Targeted Drug Delivery.

Leach JC, Wang A, Ye K, Jin S.

Int J Mol Sci. 2016 Mar 14;17(3):380. doi: 10.3390/ijms17030380.

8.

Aptamers: A promising chemical antibody for cancer therapy.

Zhou G, Wilson G, Hebbard L, Duan W, Liddle C, George J, Qiao L.

Oncotarget. 2016 Mar 22;7(12):13446-63. doi: 10.18632/oncotarget.7178. Review.

9.

RNA as a stable polymer to build controllable and defined nanostructures for material and biomedical applications.

Li H, Lee T, Dziubla T, Pi F, Guo S, Xu J, Li C, Haque F, Liang XJ, Guo P.

Nano Today. 2015 Oct 1;10(5):631-655.

10.

Cell Nucleus-Targeting Zwitterionic Carbon Dots.

Jung YK, Shin E, Kim BS.

Sci Rep. 2015 Dec 22;5:18807. doi: 10.1038/srep18807.

11.
12.

Pharmacokinetics, pharmacodynamics and toxicology of theranostic nanoparticles.

Kang H, Mintri S, Menon AV, Lee HY, Choi HS, Kim J.

Nanoscale. 2015 Dec 7;7(45):18848-62. doi: 10.1039/c5nr05264e. Epub 2015 Nov 3. Review.

13.

Threshold Dose of Three Types of Quantum Dots (QDs) Induces Oxidative Stress Triggers DNA Damage and Apoptosis in Mouse Fibroblast L929 Cells.

Zhang T, Wang Y, Kong L, Xue Y, Tang M.

Int J Environ Res Public Health. 2015 Oct 26;12(10):13435-54. doi: 10.3390/ijerph121013435.

14.

Progress and Challenges in Developing Aptamer-Functionalized Targeted Drug Delivery Systems.

Jiang F, Liu B, Lu J, Li F, Li D, Liang C, Dang L, Liu J, He B, Badshah SA, Lu C, He X, Guo B, Zhang XB, Tan W, Lu A, Zhang G.

Int J Mol Sci. 2015 Oct 9;16(10):23784-822. doi: 10.3390/ijms161023784. Review.

15.

Expansile crosslinked polymersomes for pH sensitive delivery of doxorubicin.

Liu X, Yaszemski MJ, Lu L.

Biomater Sci. 2016 Feb;4(2):245-9. doi: 10.1039/c5bm00269a.

PMID:
26442597
16.

The Role of Molecular Imaging in Drug Delivery.

Niu G, Chen X.

Drug Deliv (Lond). 2009;3:109-113.

17.

Addressing Key Technical Aspects of Quantum Dot Probe Preparation for Bioassays.

Zrazhevskiy P, Dave SR, Gao X.

Part Part Syst Charact. 2014 Dec 1;31(12):1291-1299.

18.

Nucleic Acid Aptamers: An Emerging Tool for Biotechnology and Biomedical Sensing.

Ku TH, Zhang T, Luo H, Yen TM, Chen PW, Han Y, Lo YH.

Sensors (Basel). 2015 Jul 6;15(7):16281-313. doi: 10.3390/s150716281. Review.

19.

DNA Polyplexes as Combinatory Drug Carriers of Doxorubicin and Cisplatin: An in Vitro Study.

Kang HC, Cho H, Bae YH.

Mol Pharm. 2015 Aug 3;12(8):2845-57. doi: 10.1021/mp500873k. Epub 2015 Jul 13.

20.

A dual wavelength-activatable gold nanorod complex for synergistic cancer treatment.

Pacardo DB, Neupane B, Rikard SM, Lu Y, Mo R, Mishra SR, Tracy JB, Wang G, Ligler FS, Gu Z.

Nanoscale. 2015 Jul 28;7(28):12096-103. doi: 10.1039/c5nr01568e. Epub 2015 Jun 30.

Items per page

Supplemental Content

Write to the Help Desk